Researchers are to trial Botox to treat hay fever after early tests showed promising results. Under the trial, a Botox gel will be applied to the nose to hopefully give hay fever sufferers relief from sneezing, itchy eyes and runny noses for up to three months. It is hoped that the botulinum toxin will affect the nerves in the nose and potentially block some of the chemicals released by the nerve endings which play a large role in causing hay fever symptoms. Australian scientists have re-engineered the Botox molecule to be able to penetrate through the skin but also through the lining of the nose in a bid to treat the allergy. Philip Bardin, a professor at the Monash Medical Centre, said that Botox was already widely used in medicine to reduce spasms in muscles following strokes and in treating cerebral palsy. "This is very new way to use an old medication," the Daily Mail quoted him as saying. Botox, which makes muscles relax, is a purified form of a nerve poison and is produced by bacteria that cause a disease which paralyses muscles. 70 people will be recruited for the new study following a preliminary trial that suggested the drug provided relief. ( ANI
GMT 10:31 2018 Tuesday ,13 November
Russian police uproot 70 underground drug labs in past six monthsGMT 16:32 2018 Tuesday ,06 November
Rwanda aims to achieve universal access to clean water by 2024GMT 16:57 2018 Sunday ,04 November
Palestinian women witness higher cure rate of breast cancerGMT 13:11 2018 Tuesday ,30 October
Emergency surgery saves life of touristGMT 10:44 2018 Tuesday ,23 October
Scientists find microplastics in human stool for first timeGMT 09:18 2018 Tuesday ,23 October
US judge upholds Monsanto weedkiller cancer verdict, reduces payoutGMT 14:22 2018 Friday ,19 October
Birth spacing ‘improving health of Omani women’GMT 15:40 2018 Monday ,15 October
Pakistani president launches nationwide anti-measles driveMaintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2025 ©
Maintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2025 ©
Send your comments
Your comment as a visitor